M&A Deal Summary

Abbott Laboratories Acquires Alere

On February 1, 2016, Abbott Laboratories acquired healthcare services company Alere for 5.8B USD

Acquisition Highlights
  • This is Abbott Laboratories’ 1st transaction in the Healthcare Services sector.
  • This is Abbott Laboratories’ 4th largest (disclosed) transaction.
  • This is Abbott Laboratories’ 22nd transaction in the United States.
  • This is Abbott Laboratories’ 3rd transaction in Massachusetts.

M&A Deal Summary
Date 2016-02-01
Target Alere
Sector Healthcare Services
Buyer(s) Abbott Laboratories
Deal Type Add-on Acquisition
Deal Value 5.8B USD
Advisor(s) J.P. Morgan Securities (Financial)
Cravath, Swaine & Moore (Legal)

Target

Alere

Waltham, Massachusetts, United States
Alere delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Alere was founded in 1981 and is based in Waltham, Massachusetts.

Search 201,539 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abbott Laboratories

North Chicago, Illinois, United States
Category Company
Founded 1888
Sector Medical Products
Employees114,000
Revenue 40.1B USD (2023)
DESCRIPTION
Entrance to Abbott's corporate campus in Abbott Park, Illinois.
Entrance to Abbott's corporate campus in Abbott Park, Illinois.

Abbott Laboratories is a diversified, global provider of diagnostics, medical devices, nutrition and pharmaceuticals. Abbott Laboratories was incorporated in 1888 and is headquartered in North Chicago, Illinois.

DEAL STATS #
Overall 29 of 35
Sector (Healthcare Services) 1 of 1
Type (Add-on Acquisition) 29 of 35
State (Massachusetts) 3 of 3
Country (United States) 22 of 28
Year (2016) 1 of 3
Size (of disclosed) 4 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-30 Tendyne Holdings

Roseville, Minnesota, United States

Tendyne Holdings, Inc. is a medical device company focused on developing minimally invasive mitral valve replacement therapies.

Buy $250M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-05 Kalila Medical

Campbell, California, United States

Kalila Medical, Inc. is a medical device company developing next-generation access technologies used in cardiac electrophysiology procedures for the treatment of heart rhythm disorders, including atrial fibrillation.

Buy -
Mergr

Product

Company

Legal